Yatin Suneja Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
57
Avg Return
Past Year
Past Year
66%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $60 |
13%
downside
| 1 | +13% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $100 |
1,117%
upside
| 1 | +185% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $200 |
114%
upside
| 1 | +58% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $50 |
15%
upside
| 1 | +12% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $25 |
90%
upside
| 1 | +82% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $1,120 |
32%
upside
| 1 | +6% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $220 |
16%
upside
| 1 | +9.8% |
0
%
| 24 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $800 |
134%
upside
| 1 | +27% |
0
%
| 10 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $975 |
30%
upside
| 1 | +6.7% |
0
%
| 9 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $246 |
39%
upside
| 1 | -8.5% |
0
%
| 9 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $30 |
1%
upside
| 1 | +40% |
0
%
| 9 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $44 |
50%
upside
| 1 | +18% |
0
%
| 9 Feb ‘26 2 months ago |
|
|
|
Buy
Initiated
| $50 |
247%
upside
| 1 | +5.3% |
0
%
| 2 Feb ‘26 2 months ago |
|